184 related articles for article (PubMed ID: 27122712)
1. Warfarin Pharmacogenetics: New Life for an Old Drug.
Wen MS; Lee MT
Acta Cardiol Sin; 2013 May; 29(3):235-42. PubMed ID: 27122712
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of warfarin: challenges and opportunities.
Lee MT; Klein TE
J Hum Genet; 2013 Jun; 58(6):334-8. PubMed ID: 23657428
[TBL] [Abstract][Full Text] [Related]
3. Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
Chen W; Wu L; Liu X; Shen Y; Liang Y; Zhu J; Tan H; Yang Y; Liu Q; Wang M; Liu L; Wang X
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):126-132. PubMed ID: 27117036
[TBL] [Abstract][Full Text] [Related]
4. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
[TBL] [Abstract][Full Text] [Related]
5. An analysis of the relative effects of VKORC1 and CYP2C9 variants on anticoagulation related outcomes in warfarin-treated patients.
Meckley LM; Wittkowsky AK; Rieder MJ; Rettie AE; Veenstra DL
Thromb Haemost; 2008 Aug; 100(2):229-39. PubMed ID: 18690342
[TBL] [Abstract][Full Text] [Related]
6. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.
Yin T; Miyata T
Thromb Res; 2007; 120(1):1-10. PubMed ID: 17161452
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
Farzamikia N; Sakhinia E; Afrasiabirad A
Lab Med; 2017 Dec; 49(1):25-34. PubMed ID: 29182754
[TBL] [Abstract][Full Text] [Related]
8. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
[TBL] [Abstract][Full Text] [Related]
9. [Companion Diagnostics for Thrombotic Disease].
Masuda Y; Matsuno K; Shimizu C
Rinsho Byori; 2015 Nov; 63(11):1316-22. PubMed ID: 26995878
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of warfarin.
Kamali F; Wynne H
Annu Rev Med; 2010; 61():63-75. PubMed ID: 19686083
[TBL] [Abstract][Full Text] [Related]
11. The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians.
Bedewy AML; Sheweita SA; Mostafa MH; Kandil LS
Indian J Hematol Blood Transfus; 2018 Apr; 34(2):328-336. PubMed ID: 29622878
[TBL] [Abstract][Full Text] [Related]
12. Genetic Warfarin-Resistance Resulting in Surgery to Change a Prosthetic Valve.
Malik J; Ishaq U; Javed N; Baig MA; Javaid M
Eur J Case Rep Intern Med; 2020; 7(11):001851. PubMed ID: 33194861
[TBL] [Abstract][Full Text] [Related]
13. Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis.
Zhang J; Chen Z; Chen C
Meta Gene; 2016 Sep; 9():197-209. PubMed ID: 27617219
[TBL] [Abstract][Full Text] [Related]
14. VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts).
Chertovskikh YV; Malova EU; Maksimova NR; Popova NV; Sychev DA
Int J Risk Saf Med; 2015; 27 Suppl 1():S17-8. PubMed ID: 26639691
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
Park YK; Lee MJ; Kim JH; Lee JS; Park RW; Kim GM; Chung CS; Lee KH; Kim JS; Lee SY; Bang OY
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1383-1390. PubMed ID: 28412319
[TBL] [Abstract][Full Text] [Related]
16. Extremely low warfarin dose in patients with genotypes of CYP2C9*3/*3 and VKORC1-1639A/A.
Gao L; He L; Luo J; Xu B; Yang J; Zhang YX; Yang T; Li K; Tian JW; Wang HJ; Zhao YS; Lu CY; Zhang WZ; Yin T
Chin Med J (Engl); 2011 Sep; 124(17):2767-70. PubMed ID: 22040439
[TBL] [Abstract][Full Text] [Related]
17. The Genetics of Warfarin Dose-Response Variability in Africans: An Expert Perspective on Past, Present, and Future.
Ndadza A; Thomford NE; Mukanganyama S; Wonkam A; Ntsekhe M; Dandara C
OMICS; 2019 Mar; 23(3):152-166. PubMed ID: 30883300
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of genetic factors for warfarin dose prediction.
Caldwell MD; Berg RL; Zhang KQ; Glurich I; Schmelzer JR; Yale SH; Vidaillet HJ; Burmester JK
Clin Med Res; 2007 Mar; 5(1):8-16. PubMed ID: 17456829
[TBL] [Abstract][Full Text] [Related]
19. [Warfarin resistance and related pharmacogenetic information].
Takahashi H
Brain Nerve; 2008 Nov; 60(11):1365-71. PubMed ID: 19069171
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
